Mr. Muiris O'Connor:

Yes. The UK was not an obvious partner for this kind of thing. The UK, Germany and France tend to have an "I'm all right, Jack" approach to the supply of medicines. Our organisation, the HPRA, is looking at matters such as the scale of the Irish market, packaging and so on. Again, the best of all possible scenarios is the UK maintaining equivalence with the medical regulations pertaining in the European Union and the packages remaining the same. However, we are already working with other countries in mainland Europe to explore dual-language packaging and guidance leaflets. As the committee recommended in its report, any changes or developments in this regard, or even no developments, should be accompanied by public awareness-raising, education and reassurance about safety. I ask Mr. Smyth to respond to the question about the cross-border health care directive.